☰

Adam Vigil, Ph.D. - Publications

Affiliations: 
2008 Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Area:
Virology Biology, Genetics, Immunology
Tree Info Similar researchers PubMed Report error

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Dambra R, Matter A, Graca K, Akhand SS, Mehta S, Bell-Cohn A, Swenson JM, Abid S, Xin D, Lewis C, Coyle L, Wang M, Bunosso K, Maugiri M, Ruiz R, ... ... Vigil A, et al. Nonclinical pharmacokinetics and biodistribution of VSV-GP using methods to decouple input drug disposition and viral replication. Molecular Therapy. Methods & Clinical Development. 28: 190-207. PMID 36700123 DOI: 10.1016/j.omtm.2022.12.013  0.515
2020 Vigil A, Frias-Staheli N, Carabeo T, Wittekind M. Airway Delivery of Anti-influenza Monoclonal Antibodies Results in Enhanced Antiviral Activities and Enables Broad-Coverage Combination Therapies. Journal of Virology. 94. PMID 32847855 DOI: 10.1128/JVI.00052-20  0.462
2018 Vigil A, Estélles A, Kauvar LM, Johnson SK, Tripp RA, Wittekind M. Native human monoclonal antibodies with potent cross-lineage neutralization of influenza B viruses. Antimicrobial Agents and Chemotherapy. PMID 29507069 DOI: 10.1128/AAC.02269-17  0.452
2009 Zamarin D, Martínez-Sobrido L, Kelly K, Mansour M, Sheng G, Vigil A, García-Sastre A, Palese P, Fong Y. Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 697-706. PMID 19209145 DOI: 10.1038/Mt.2008.286  0.549
2008 Vigil A, Martinez O, Chua MA, García-Sastre A. Recombinant Newcastle disease virus as a vaccine vector for cancer therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1883-90. PMID 18714310 DOI: 10.1038/mt.2008.181  0.464
2007 Vigil A, Park MS, Martinez O, Chua MA, Xiao S, Cros JF, Martínez-Sobrido L, Woo SL, García-Sastre A. Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus. Cancer Research. 67: 8285-92. PMID 17804743 DOI: 10.1158/0008-5472.Can-07-1025  0.461
Show low-probability matches.